Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06467513
PHASE4

To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

Sponsor: Zhang XIao Mei

View on ClinicalTrials.gov

Summary

The objective of this study was to evaluate the effect of esketamine on intraoperative hemodynamics in patients with heart valve replacement and to mitigate postoperative pulmonary complications

Official title: To Investigate the Effect of Esketamine on Hemodynamics and Postoperative Pulmonary Complications in Patients Undergoing Heart Valve Replacement Surgery

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2024-01-01

Completion Date

2025-05

Last Updated

2024-06-21

Healthy Volunteers

No

Interventions

DRUG

Esketamine hydrochloride injection

The low dose esketamine hydrochloride group was given 0.2mg/kg at induction of anesthesia, the high dose esketamine hydrochloride group was given 0.4mg/kg at induction of anesthesia, and the blank control group was not given Esketamine hydrochloride injection at induction of anesthesia.

Locations (1)

Affiliated Hospital of Zunyi Medical University

Zunyi, Guizhou, China